Recent reports have suggested that the total number of autologous or allogeneic hematopoietic stem cell (HSC) infused after high-dose chemotherapy might predict survival, post-transplant morbidity and rate of hematopoietic engraftment. However, HSC capable of long-term multilineage potential are still poorly defined, and tools for accurate and reproducible HSC enumeration are highly warranted.
|Journal||Bone Marrow Transplantation|
|Issue number||SUPPL. 1|
|Publication status||Published - 1998|
- Stem cell
ASJC Scopus subject areas